viernes, 13 de febrero de 2026

Moderna’s president weighs in on FDA’s decision not to review its flu vaccine In interview, Stephen Hoge took questions on the impact on the company and others in industry

https://www.statnews.com/2026/02/12/moderna-stephen-hoge-interview-flu-vaccine/ By Matthew Herper, Adam Feuerstein, Elaine Chen, and Allison DeAngelisFeb. 12, 2026

No hay comentarios:

Publicar un comentario